- $1.46bn
- $1.28bn
- $2.80m
Brief: Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Absci Strengthens Clinical Leadership With Appointment Of Ransi Somaratne, M.D., FACC, Mba As Chief Medical Officer
Brief: Absci Announces First Participants Dosed In Phase 1/2A Headline Trial
Absci Q3 net loss widens
Brief: Absci Q3 Revenue USD 378 Thousand Vs. IBES Estimate USD 1.52 Million
U.S. RESEARCH ROUNDUP- Absci, Bloom Energy, Corteva
U.S. STOCKS ON THE MOVE-Opendoor Technologies, AIRO Group, Camurus
U.S. STOCKS ON THE MOVE-Opendoor Technologies, AIRO Group, Camurus
U.S. STOCKS ON THE MOVE -Apple, Enovix, Kroger
Absci rises on collaboration with AMD and Oracle for AI drug discovery
Brief: Absci Accelerates AI-Driven Drug Discovery With Oracle And AMD
Absci Corp reports results for the quarter ended June 30 - Earnings Summary
Absci Corp expected to post a loss of 21 cents a share - Earnings Preview
Spanish stocks - Factors to watch on Aug 7
Brief: Almirall And Absci Expand AI Drug Creation Collaboration Adding Second Dermatology Target
U.S. STOCKS ON THE MOVE-Meta, Centene, Silver Miners
U.S. STOCKS ON THE MOVE-Boston Beer, GE Vernova, Absci Corp
U.S. STOCKS ON THE MOVE-HCA Healthcare, Phillips 66, Booz Allen
U.S. STOCKS ON THE MOVE-Estee Lauder, Coursera, Paramount